SPONSOR
Changhai Hospital
Total Trials
10
Recruiting
10
Phases
Phase 1, Phase 1, Phase 2, Phase 4, EARLY_Phase 1
Conditions studied: Chronic Hepatitis bPancreatic CancerPancreatic NeoplasmsPancreatic Ductal AdenocarcinomaAdvanced CancerAcute Ischemic StrokeLarge Vessel OcclusionThrombectomyThrombosisChronic Pancreatitis
Changhai Hospital is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Chronic Hepatitis b, Pancreatic Cancer, Pancreatic Neoplasms, Pancreatic Ductal Adenocarcinoma.
The trial portfolio spans Phase 1, Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Changhai Hospital
How many clinical trials has Changhai Hospital sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Changhai Hospital, of which 10 are actively recruiting participants. These trials cover conditions including Chronic Hepatitis b, Pancreatic Cancer, Pancreatic Neoplasms. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Changhai Hospital research focus on?
Changhai Hospital clinical trials span Chronic Hepatitis b, Pancreatic Cancer, Pancreatic Neoplasms, Pancreatic Ductal Adenocarcinoma, Advanced Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Changhai Hospital clinical trial?
To participate in a Changhai Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Changhai Hospital trials with current recruitment status updated daily.
Clinical Trials by Changhai Hospital
NCT06885710 Phase 1
Recruiting
HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
Chronic Hepatitis b
NCT04146298 Phase 1, Phase 2
Recruiting
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
Pancreatic Cancer
NCT05864638
Recruiting
Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study
Acute Ischemic Stroke
NCT06937294 Phase 4
Recruiting
Metformin in Post Chronic Pancreatitis Diabetes Mellitus
Chronic Pancreatitis
NCT06010472 EARLY_Phase 1
Recruiting
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
NCT04743479
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Pancreatic Cancer
NCT06346093
Recruiting
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
Advanced Gastric Cancer
NCT07425483 Phase 1
Recruiting
CAR-NK Cells (CL-NK-003) in Pancreatic Cancer
Pancreatic Cancer
NCT07088757 Phase 4
Recruiting
Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis
Post-ERCP Pancreatitis
NCT06325995
Recruiting
Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer
Localized Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology